Guangzhou International Finance Center
China - Map
Biostime International Holdings Limited, an investment holding company, provides pediatric nutritional and baby care products to mothers primarily in the Peoples Republic of China. The company operates through five segments: Infant Formulas, Adult Nutrition and Care Products, Probiotic Supplements, Dried Baby Food and Nutrition Supplements, and Baby Care Products. The Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment offers vitamins, health supplements, skin care, and sports nutrition products for adults. The Probiotic Supplements segment produces probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The Dried Baby Food and Nutrition Supplements segment engages in the production of dried baby food products made from natural foods for infants and young children; and microencapsulated milk calcium chewable tablets for children, and pregnant and lactating mothers. The Baby Care Products segment provides baby care products for infants and children, including baby diapers and toiletry kits, as well as personal care products for nursing mothers, such as nursing pads. The company is also involved in the wholesale, retail, import, and export of personal care products for infants; trading of infant food and nutritional products; early childhood education advisory business; and trading of related baby supplies, as well as offers online software and information technology services. It sells its products and services through distributors under the Biostime, Adimil, BMcare, and Parenting Power brands. The company was founded in 1999 and is headquartered in Guangzhou, China. Biostime International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
|Mr. Fei Luo ,
Chairman, Chief Exec. Officer, Chairman of Nomination Committee and Member of Remuneration Committee
|Mr. Yidong Wang ,
Chief Fin. Officer
|Dr. Patrice Malard ,
Chief Technology Officer, Chief Scientific Officer, Gen. Mang. of The Technology Center - Biostime Health and Gen. Mang. of Biostime Pharma
|Ms. Wenyun Yang ,
Director of Corp. Affairs & HR Department and Joint Company Sec.
|Mr. Radek Sali ,
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in HKD.|